12:27 PM EST - Optimi Health : Has submitted a request with Health Canada for an amendment to its Controlled Substances Dealer’s Licence. The amendment would enable the Company to synthesize, process and distribute pharmaceutical grade 3,4-Methylenedioxymethamphetamine (MDMA), among other substances, at its Princeton, British Columbia facility. Optimi Health
shares C.OPTI are trading up $0.02 at $0.26.
